The Shelf

Edit Metric

Company
Value
Source
Source URL
Notes
		Cancel

Edit | History

Details

Company:
Value :
Source:
Source URL:
Notes:

Meet our Contributors | Get Involved

Eli Lilly and Company (LLY)

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

FDA delays review of blood thinner The FDA announced that it needs more time to review the application for Eli Lilly's blood thinner prasugrel. Lilly 2Q profit up 44 percent Eli Lilly posted a net income of $958.8 million, compared to $663.3 million last year. Revenue increased by 11 percent to $5.15 billion. Eli Lilly buys cancer biotech for $64 million Eli Lilly buys SGX Pharmaceuticals, a biotech with a focus on cancer drugs, for $64 million in cash. Lilly shares jump after analyst upgrade Eli Lilly shares increased by $2.75, or 5.3 percent, to $54.55 after the company announced a strong than expected earnings forecast and analysts upgraded the company to 'equal weight.' Eli Lilly earnings forecast beats expectations Shares gained 1.9% to $53.49, after Eli Lilly announced earnings expectations above analyst estimates. The company predicted 2008 EPS of $3.85 to $4.00, while analysts expected $3.82. In spite of a 39% drop in Q1 earnings, Lilly still News about Lilly's acquisition of partner ICOS Cor News about an impending N

Worried about pump and dump?

We review changes
for stock spam

» read more

Want to make Wikinvest better?

We need your help,
contribute today

» learn how

Do you write software?

We are recruiting
the best engineers

» view jobs

Like Wikinvest?

Spread the word —
Tell your friends!

» spread the word

Wikinvest © 2006, 2007, 2008. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.